FOLOTYN (PRALATREXATE INJECTION) Trademark

Trademark Overview

On Thursday, August 27, 2009, a trademark application was filed for FOLOTYN (PRALATREXATE INJECTION) with the United States Patent and Trademark Office. The USPTO has given the FOLOTYN (PRALATREXATE INJECTION) trademark a serial number of 77813881. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, January 26, 2021. This trademark is owned by Allos Therapeutics, Inc.. The FOLOTYN (PRALATREXATE INJECTION) trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
folotyn (pralatrexate injection)

General Information

Serial Number77813881
Word MarkFOLOTYN (PRALATREXATE INJECTION)
Filing DateThursday, August 27, 2009
Status800 - REGISTERED AND RENEWED
Status DateTuesday, January 26, 2021
Registration Number3874615
Registration DateTuesday, November 9, 2010
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 22, 2009

Trademark Statements

Description of MarkThe mark consists of the word "FOLOTYN" in plum above the phrase (pralatrexate injection) in avocado green, adjacent to a loose flower design consisting of opposing spaced sets of spring and avocado green petals receiving a plum droplet from above.
Goods and ServicesPharmaceutical preparations for the treatment of cancer
Indication of Colors claimedThe color(s) plum, spring green and avocado green is/are claimed as a feature of the mark.
NOT AVAILABLE"PRALATREXATE INJECTION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 2, 2009
Primary Code005
First Use Anywhere DateMonday, May 10, 2010
First Use In Commerce DateMonday, May 10, 2010

Trademark Owner History

Party NameACROTECH BIOPHARMA INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressEAST WINDSOR, NJ 08520
Party NameACROTECH BIOPHARMA LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressEAST WINDSOR, NJ 08520
Party NameAllos Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020
Party NameAllos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020
Party NameAllos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020

Trademark Events

Event DateEvent Description
Tuesday, September 1, 2009NEW APPLICATION ENTERED
Wednesday, September 2, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 3, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Monday, October 26, 2009ASSIGNED TO EXAMINER
Monday, November 2, 2009EXAMINER'S AMENDMENT ENTERED
Monday, November 2, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, November 2, 2009EXAMINERS AMENDMENT E-MAILED
Monday, November 2, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 2, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 19, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 22, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, November 19, 2009ASSIGNED TO LIE
Tuesday, December 22, 2009PUBLISHED FOR OPPOSITION
Monday, February 15, 2010TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, March 9, 2010ASSIGNED TO PETITION STAFF
Wednesday, August 4, 2010TEAS STATEMENT OF USE RECEIVED
Friday, August 27, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 15, 2010SOU TEAS EXTENSION RECEIVED
Thursday, September 30, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 4, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, March 10, 2010CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, March 16, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 4, 2010USE AMENDMENT FILED
Friday, August 27, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 9, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, February 13, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, November 18, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 29, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 29, 2020TEAS SECTION 8 & 9 RECEIVED
Tuesday, October 5, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 9, 2016TEAS SECTION 8 & 15 RECEIVED
Friday, November 18, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 18, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 9, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 26, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, June 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 14, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 21, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 26, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, January 26, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Related Keywords

injection pralatrexate folotyn cancer treatment preparations pharmaceutical